Search results
Results from the WOW.Com Content Network
Vaping-associated pulmonary injury (VAPI), [4] also known as vaping-associated lung injury (VALI) [1] or e-cigarette, or vaping, product use associated lung injury (E/VALI), [2] [a] is an umbrella term, [15] [16] used to describe lung diseases associated with the use of vaping products that can be severe and life-threatening. [3]
Dylan Nelson, 26, of Burlington, Wisconsin, was put into a medically induced coma when his body started shutting down after vaping. His brother says Dylan bought the vape cartridge off the street ...
The 18-year-old patient says she bought vaping products from a smoke shop that did not ask for her ID card, enabling her to lie and claim that she was 22. [117] Dizziness, vomiting, abdominal pain, difficulty breathing, necessitating supplemental oxygen. [118] [119] Breathing problems mistaken for the flu or stomach virus, eventually requiring ...
Research shows that exposure to air pollution known as particle pollution can lead to higher incidence of heart attacks and other significant health problems. If vaping is significantly affecting ...
Whether long-term vaping can raise the chance for malignancy in individuals with a susceptibility for tumor growth is unknown. [202] The effects of nicotine on the sympathoadrenal system could stimulate the advancement of cancer in people who have cancer. [203] Nicotine has been shown to induce DNA damage in the Escherichia colipol A+/pol− ...
In addition to containing varying levels of the addictive substance nicotine, they also contain other cancer-causing chemicals, such as formaldehyde, and as our study shows, flavoring chemicals ...
A new study indicates that people who have used a vape at any point in their lives are 19% more likely to experience heart failure compared to people who have never used them.
A 2018 Cochrane review found that, in rare cases, nicotine replacement therapy can cause non-ischemic chest pain (i.e., chest pain that is unrelated to a heart attack) and heart palpitations, but does not increase the incidence of serious cardiac adverse events (i.e., myocardial infarction, stroke, and cardiac death) relative to controls.